Witte Torsten
Abteilung Klinische Immunologie und Rheumatologie, Carl-Neuberg Str. 1, 30625, Hannover, Germany.
Clin Rev Allergy Immunol. 2008 Jun;34(3):345-7. doi: 10.1007/s12016-007-8046-x.
IgG antibodies against dsDNA are involved in the pathogenesis of systemic lupus erythematosus (SLE) glomerulonephritis. In contrast, glomerulonephritis is rare in SLE patients with IgM antibodies against dsDNA. Therefore, a possible protective effect of IgM antibodies has been studied in more detail. In murine models of SLE, the lack of secreted IgM was associated with more severe glomerulonephritis. In more recent studies, the treatment of lupus-prone mice with a murine IgM monoclonal antibody against dsDNA prevented renal damage. Furthermore, the clearance of pathogenic immune complexes may be improved by IgM. Therefore, IgM antibodies against dsDNA are indeed protective and may be a new treatment modality of lupus nephritis in humans.
抗双链DNA的IgG抗体参与系统性红斑狼疮(SLE)肾小球肾炎的发病机制。相比之下,在具有抗双链DNA IgM抗体的SLE患者中,肾小球肾炎较为罕见。因此,对IgM抗体可能的保护作用进行了更详细的研究。在SLE小鼠模型中,缺乏分泌型IgM与更严重的肾小球肾炎相关。在最近的研究中,用抗双链DNA的鼠IgM单克隆抗体治疗易患狼疮的小鼠可预防肾脏损伤。此外,IgM可能会改善致病性免疫复合物的清除。因此,抗双链DNA的IgM抗体确实具有保护作用,可能是人类狼疮性肾炎的一种新的治疗方式。